Michael Meister
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 30
- Lung Cancer Diagnosis and Treatment 11
- Oncology 42
- Lung Cancer Research Studies 17
- Cancer Cells and Metastasis 9
- Co-authors
- Thomas Muley (90 shared papers)Arne Warth (35 shared papers)Frédéric Laquai (14 shared papers)Michael Thomas (47 shared papers)Ian A. Howard (6 shared papers)Philipp A. Schnabel (27 shared papers)Hendrik Dienemann (31 shared papers)Marc A. Schneider (33 shared papers)
- Journals
- Lung Cancer (11 papers)Journal of Thoracic Oncology (9 papers)Cancers (7 papers)Annals of Oncology (5 papers)International Journal of Cancer (4 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Michael Meister
155 papers receiving 7.0k citations
Michael Meister's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 1.5k
- Polymers and Plastics 630
- Oncology 1.1k
- Infectious Diseases 725
Countries citing papers authored by Michael Meister
This map shows the geographic impact of Michael Meister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Meister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Meister more than expected).
Fields of papers citing papers by Michael Meister
This network shows the impact of papers produced by Michael Meister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Meister. The network helps show where Michael Meister may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Meister, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells Hit paper breakdown → | 2020 | 720 |
| 2 | The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival Hit paper breakdown → | 2012 | 559 |
| 3 | 2007 | 385 | |
| 4 | 2010 | 351 | |
| 5 | 2020 | 262 | |
| 6 | 2011 | 261 | |
| 7 | 2014 | 233 | |
| 8 | 2012 | 181 | |
| 9 | 2017 | 159 | |
| 10 | 2008 | 155 | |
| 11 | 2015 | 148 | |
| 12 | 2017 | 137 | |
| 13 | 2016 | 126 | |
| 14 | 2008 | 120 | |
| 15 | 2017 | 114 | |
| 16 | 2014 | 107 | |
| 17 | 2012 | 98 | |
| 18 | 2011 | 93 | |
| 19 | 2009 | 84 | |
| 20 | 2019 | 84 |
About Michael Meister
Michael Meister is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Electrical and Electronic Engineering, having authored 157 papers that have together received 7.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Cancer Genomics and Diagnostics (20 papers), Lung Cancer Research Studies (17 papers), Lung Cancer Diagnosis and Treatment (11 papers), Epigenetics and DNA Methylation (10 papers), Cancer Cells and Metastasis (9 papers), Cancer-related molecular mechanisms research (9 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (1.5k citations), Polymers and Plastics (630 citations), Oncology (1.1k citations) and Infectious Diseases (725 citations). Michael Meister has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Thomas Muley, Arne Warth, Frédéric Laquai, Michael Thomas, Ian A. Howard, Philipp A. Schnabel, Hendrik Dienemann, Marc A. Schneider, Hans Hoffmann and Ralf Mauer. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, Cancers, Annals of Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.